UKCC Home

Information site for the UK Cancer Costs Questionnaire

The UKCC is a modular questionnaire designed to capture the  resources used by people with a current or previous diagnosis of cancer in the context of clinical trials or prospective research and audit

The design prioritises brevity in an attempt to minimise the burden of data collection on participants and research personnel. The tool is designed to be used alongside a clinical trial or trial-standard data collection within an observational study, without duplicating standard data collection on case report forms.

Each question can be used in isolation, but we recommend keeping modules together. The questions can be administered on paper, over the web or over the phone.

Captured activity may currently include NHS primary care, NHS community care, medications and personal social services. Societal costs are also captured including patient out-of-pocket costs, costs incurred by carers and time taken off work.

The UKCC is registered on the DIRUM database.

Version 4 of the UKCC is under development. The questionnaire is likely to fork into curative and palliative contextual versions.

The UKCC development programme is a collaboration between the Health Economics groups at the Universitys of Edinburgh, Leeds and Exeter.

Download the UKCC

Version 3.0 July 2019: UK Cancer Costs Questionnaire v3-0  [Editable version: UK Cancer Costs Questionnaire v3-0 ]

Version 2.7 October 2018:  UK Cancer Costs Questionnaire v2.7

Using the UKCC

The UKCC is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

The license allows you to use and modify the UKCC, with the understanding that you will make your modified version available to future researchers.

If you are using the UKCC please cite this webpage at http://blogs.ed.ac.uk/ukcc

Please let us know at p.s.hall[at]ed.ac.uk if you are using it. We would love to add your study to our growing list with your modified version below. We seek to learn from new iterations for incorporation into the next version.

Study-specific versions of the UKCC

The tool has been developed in the context of a series of UK clinical trials. Some of the study-specific versions are available to download.

• Breast cancer
  • OPTIMA
  • Mammo-50
  • Persephone
  • PETNECK

  • CardiacCARE

    • UKCC_v2_CardiacCARE_2017-02-07_Baseline_open

    • UKCC_v2_CardiacCARE_2017-02-07_Follow-up_open
  • ROSELEE (A real world study of ribociclib for metastatic breast cancer)

• Lung cancer

  • SABRTOOTH

• Kidney cancer
  • STAR
• Bowel cancer
  • EMT-2
  • the CITRuS Trial (To examine whether a Complex Intervention protocol decreases Toxicity in patients following Radiotherapy or Surgery for colorectal cancer with electronic data collection, a feasibility trial of data collection. PI Dr Alexandra Stewart, Royal Surrey County Hospital
• Bladder Cancer
  • Q-ABC study [Nikapota et al. 2016]

• Chemotherapy
  • ACUFOCIN (accupuncture for peripheral neuropathy)
• Cancer rehabilitation
  • Realist Evaluation and Economic Analysis of Cancer Rehabilitation Services in South Wales (REEACaRS)
    • UK_Cancer_Costs_Questionnaire_REEACaRS
• Palliative care
  • ENERGY  (Hall et al. 2018)

Other studies using the standard version

• LOGICAN – Oxaliplatin in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
  https://clinicaltrials.gov/ct2/show/NCT05476796

The UKCC has now diversified into post-intensive care follow-up with the ABC Post-ICU Survivourship Trial (CI Prof Tim Walsh, University of Edinburgh).

• • ABC_HE Questionnaire_Baseline_Version1_22Jul2019
  • ABC_HE Questionnaire_1month_Version1_22Jul2019

Example analyses using the UKCC

Marti, J., Hall, P.S., Hamilton, P., Hulme, C.T., Jones, H., Velikova, G., Ashley, L. and Wright, P., 2016. The economic burden of cancer in the UK: a study of survivors treated with curative intent. Psycho‐Oncology, 25(1), pp.77-83. https://doi.org/10.1002/pon.3877

Mehanna, H., McConkey, C.C., Rahman, J.K., Wong, W.L., Smith, A.F., Nutting, C., Hartley, A.G., Hall, P., Hulme, C., Patel, D.K. and Zeidler, S.V.V., 2017. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography–computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. Health Technology Assessment, 21(17). https://www.ncbi.nlm.nih.gov/books/NBK425612/

Journal of Clinical Oncology 2018 36:15_suppl, 506-506 

References